Overview


According to FutureWise analysis the market for Aptamer in 2023 is US$ 0.21 billion, and is expected to reach US$ 0.75 billion by 2031 at a CAGR of 17.30%.

An aptamer is a short, single-stranded genetic molecule composed of DNA, RNA, or sometimes a peptide. Its three-dimensional structure allows it to bind to a target molecule. This target could be a wide range of molecules, including proteins, small molecules, or even cells. Aptamers are often compared to antibodies because they convey the ability to bind to specific targets. However, aptamers are generated in vitro (outside of a living organism) through a process called SELEX (systematic evolution of ligands by exponential enrichment). SELEX involves iterative rounds of selection and amplification, where a large pool of random nucleic acid sequences is subjected to a selection process to isolate sequences that bind to a target molecule. 

Aptamers have several advantages over antibodies. They can be chemically synthesized with high purity, making them potentially more cost-effective. They are also stable under a wide range of conditions, which can be important for various applications. Additionally, they can be engineered to have specific properties, such as enhanced stability or altered binding affinities. Aptamers have found applications in various fields, including diagnostics (as detection probes), therapeutics (as drugs or drug delivery vehicles), and as research tools in molecular biology and biochemistry. They have the potential to play a significant role in medicine and biotechnology due to their versatility and specificity.

FutureWise Market Research has published a report that provides an insightful analysis aptamer market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts aptamer market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Am Biotechnologies, LLC
  • Aptagen, LLC
  • Aptamer Sciences Inc.
  • Aptamer Solutions Ltd.
  • Aptus Biotech S.L.
  • Base Pair Biotechnologies, Inc.
  • Neoventures Biotechnology Inc.
  • Somalogic, Inc.
  • Trilink Biotechnologies, Inc.
  • Vivonics, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Aptamer Market:

  • In January 2023, Aptamer Group partnered with BaseCure Therapeutics to develop Optimer-targeted therapies. Such initiatives can open new growth paths for applications of aptamers in therapeutics.
  • In March 2021, in the United States, Eastern Virginia Medical School initiated a phase I clinical trial to determine whether a tenofovir (TFV) aptamer-based biosensor (aptasensor) can detect TFV in biological fluids from women randomized to different dosing regimens representing high and low adherence.

The escalating incidence of chronic diseases, including cancer, cardiovascular disorders, and infectious diseases, has spurred a pressing need for more precise and efficient diagnostic and therapeutic interventions. With their remarkable specificity and binding affinity, aptamers present a promising solution to address this demand. Their ability to precisely target and bind to disease-specific biomarkers offers a highly tailored approach to diagnosis and treatment. This is particularly crucial in personalized medicine, where tailored therapeutic solutions are paramount. As a result, the surge in chronic diseases has propelled aptamers to the forefront of biomedical research and innovation, positioning them as a pivotal driver in advancing healthcare solutions for these prevalent and debilitating conditions. Additionally, aptamers present a transformative edge over conventional antibodies in several fundamental aspects. Their heightened specificity enables precise targeting of molecules, reducing off-target effects and enhancing diagnostic or therapeutic accuracy. Moreover, the lower production costs associated with aptamers, owing to their synthetic nature, make them a cost-effective alternative for large-scale applications. Also, their chemical modifiability allows for fine-tuning and optimization, enabling researchers to tailor aptamers for diverse targets and applications, thus driving market growth. Furthermore, the continual advances in SELEX (systematic evolution of ligands by exponential enrichment) technology and complementary screening methodologies represent a significant opportunity in the aptamer market. These advancements have streamlined and refined the process of aptamer development, enabling researchers to generate molecules with enhanced binding affinity and exquisite specificity. This translates to aptamers that exhibit stronger and more precise interactions with their target molecules, holding immense promise for applications in diagnostics and therapeutics. However, Aptamers are relatively new in the market compared to other biotechnological products and may impose major barriers to market growth. The complexity and time-consuming nature of regulatory approval processes may impede their swift integration into clinical practice. This hurdle may delay the availability of aptamer-based diagnostics and therapeutics, potentially slowing down their widespread adoption and further hindering the market growth.

By Type

  • DNA-Based Aptamers
  • RNA-Based Aptamers
  • XNA-Based Aptamers

By Application

  • Diagnostics
  • Therapeutics Development
  • Research and Development
  • Other Applications

By Technology

  • SELEX
  • Other Technologies

By End User

  • Academic and Government Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Contract Research Organizations
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is driven by factors including the rising prevalence of chronic diseases, strong healthcare infrastructure, increasing research activities, and growing interest in research laboratories in the aptamer field, which is expected to accelerate the growth of the market. For instance, in April 2022, Noxxon Pharma announced its intention to showcase the top-line results from its NOX-A12 GLORIA trial in brain cancer during the annual assemblage of the American Society of Clinical Oncology. Also, various strategic initiatives by key players like partnerships, collaborations, & agreements for R&D of novel aptamers-based diagnostic and therapeutic products are factors anticipated to boost the market demand during the projection period. For example, in June 2021, SomaLogic and Ixaka Ltd joined into a research partnership with a goal to support the discovery and development of aptamers-based bispecific therapeutics. This collaboration estimates the safety and efficacy of antigen-specific SOMAmer reagents.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Aptamer Market By Type, By Application, By Technology, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aptamer Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Global Hydrosurgery System Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aptamer Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aptamer Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. DNA-Based Aptamers
        2. RNA-Based Aptamers
        3. XNA-Based Aptamers

  • 8.   Aptamer Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostics
        2. Therapeutics Development
        3. Research and Development
        4. Other Applications

  • 9.   Aptamer Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. SELEX
        2. Other Technologies

  • 10.   Aptamer Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic and Government Research Institutes
        2. Biotechnology and Pharmaceutical Companies
        3. Contract Research Organizations
        4. Other End Users

  • 11.   North America Aptamer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Aptamer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Aptamer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Aptamer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Aptamer Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Am Biotechnologies, LLC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Aptagen, LLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Aptamer Sciences Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Aptamer Solutions Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Aptus Biotech S.L.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Base Pair Biotechnologies, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Neoventures Biotechnology Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Somalogic, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Trilink Biotechnologies, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Vivonics, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients